Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 501-550 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07100106
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
PHASE1/PHASE2Recruiting
285 participants
Started: Oct 7, 2025 · Completed: Jul 31, 2030
1 condition2 sponsors5 locations
NCT07219121
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
PHASE4Recruiting
20 participants
Started: Oct 7, 2025 · Completed: May 31, 2027
4 conditions1 sponsor3 locations
NCT06649812
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
PHASE2Recruiting
120 participants
Started: Oct 7, 2025 · Completed: Sep 1, 2027
15 conditions1 sponsor48 locations
NCT07140900
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
PHASE1Recruiting
60 participants
Started: Oct 7, 2025 · Completed: Mar 30, 2030
1 condition1 sponsor4 locations
NCT07023666
Early Screening and Treatment of Heart Complication in Sickle Cell Disease
PHASE2Recruiting
100 participants
Started: Oct 7, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor2 locations
NCT07070219
A Study of CTD402 in T-ALL/LBL Patients
PHASE1/PHASE2Recruiting
54 participants
Started: Oct 7, 2025 · Completed: Dec 30, 2028
2 conditions1 sponsor4 locations
NCT07215351
Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women
NARecruiting
30 participants
Started: Oct 7, 2025 · Completed: Jan 1, 2026
2 conditions2 sponsors1 location
NCT07216443
Reduced Intensity or Nonmyeloablative Conditioning With Orca-T for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
PHASE2Recruiting
80 participants
Started: Oct 7, 2025 · Completed: Dec 31, 2028
3 conditions1 sponsor4 locations
NCT06988488
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
62 participants
Started: Oct 7, 2025 · Completed: Jun 3, 2027
1 condition1 sponsor22 locations
NCT07215104
A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) for the Treatment of Chronic Low Back Pain
NARecruiting
30 participants
Started: Oct 7, 2025 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT07116057
MOv19-BBz CAR T Cells in FRa+ Cancers
PHASE1Recruiting
10 participants
Started: Oct 7, 2025 · Completed: Oct 31, 2040
2 conditions2 sponsors1 location
NCT06961630
Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction
EARLY_PHASE1Recruiting
50 participants
Started: Oct 7, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT07188467
Testing Adapted Self-Help Plus (SH+) for Stress and Well-Being in International Students at a U.S. University
NARecruiting
50 participants
Started: Oct 7, 2025 · Completed: Jan 31, 2026
4 conditions1 sponsor1 location
NCT06965530
Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy
NARecruiting
360 participants
Started: Oct 6, 2025 · Completed: May 31, 2029
3 conditions5 sponsors2 locations
NCT06733376
Evaluating Evidenced Based Options for PTSD Treatment
NARecruiting
400 participants
Started: Oct 6, 2025 · Completed: Jun 1, 2030
1 condition1 sponsor1 location
NCT07161258
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
PHASE2Recruiting
12 participants
Started: Oct 6, 2025 · Completed: Feb 13, 2029
1 condition1 sponsor6 locations
NCT06885554
Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation
NARecruiting
60 participants
Started: Oct 6, 2025 · Completed: Jan 1, 2028
1 condition2 sponsors3 locations
NCT07140484
Sotatercept in Pulmonary Arterial Hypertension
PHASE4Recruiting
27 participants
Started: Oct 6, 2025 · Completed: Jan 1, 2030
1 condition3 sponsors1 location
NCT06851507
A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses
PHASE3Recruiting
30 participants
Started: Oct 6, 2025 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT07063745
A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
PHASE2/PHASE3Recruiting
590 participants
Started: Oct 6, 2025 · Completed: Aug 12, 2031
1 condition1 sponsor241 locations
NCT07178314
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
NARecruiting
38 participants
Started: Oct 6, 2025 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT06994338
Tirzepatide for Alcohol Use Disorder
PHASE2Recruiting
42 participants
Started: Oct 6, 2025 · Completed: Aug 31, 2026
3 conditions2 sponsors1 location
NCT07000045
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
NARecruiting
120 participants
Started: Oct 6, 2025 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06941974
Partnering With Antenatal Navigators to Transform Health in Pregnancy
NARecruiting
600 participants
Started: Oct 6, 2025 · Completed: May 31, 2029
5 conditions3 sponsors1 location
NCT07214545
External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms
NARecruiting
60 participants
Started: Oct 6, 2025 · Completed: Jan 31, 2028
2 conditions1 sponsor1 location
NCT07216781
Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans
PHASE1Recruiting
24 participants
Started: Oct 6, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor2 locations
NCT07081555
A First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metastatic Breast Cancer
PHASE1Recruiting
21 participants
Started: Oct 6, 2025 · Completed: Jun 1, 2028
2 conditions1 sponsor3 locations
NCT07206524
Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Hemodialysis-associated Thromboinflammation
NARecruiting
15 participants
Started: Oct 5, 2025 · Completed: Dec 31, 2026
4 conditions3 sponsors1 location
NCT06954831
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
PHASE2Recruiting
82 participants
Started: Oct 5, 2025 · Completed: Jan 31, 2028
4 conditions2 sponsors7 locations
NCT07199218
Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism
PHASE2Recruiting
78 participants
Started: Oct 5, 2025 · Completed: Mar 3, 2028
2 conditions1 sponsor1 location
NCT07216599
Photoacoustic Imaging of Foot Wound
NARecruiting
25 participants
Started: Oct 5, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT07205068
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
NARecruiting
100 participants
Started: Oct 4, 2025 · Completed: Nov 4, 2026
1 condition2 sponsors1 location
NCT06989437
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
PHASE2/PHASE3Recruiting
982 participants
Started: Oct 3, 2025 · Completed: Dec 23, 2029
2 conditions1 sponsor12 locations
NCT07190430
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
PHASE1Recruiting
16 participants
Started: Oct 3, 2025 · Completed: Feb 16, 2026
1 condition1 sponsor1 location
NCT06632379
AtorvaStatin Postpartum and Reduction of Cardiovascular risK
PHASE4Recruiting
76 participants
Started: Oct 3, 2025 · Completed: Dec 15, 2026
3 conditions1 sponsor1 location
NCT07001423
ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly
NARecruiting
400 participants
Started: Oct 3, 2025 · Completed: Aug 31, 2032
3 conditions1 sponsor12 locations
NCT06872645
Exploring Water-free Sodium Storage
NARecruiting
10 participants
Started: Oct 3, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT07094061
Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Translation of a Preclinical Model
NARecruiting
294 participants
Started: Oct 3, 2025 · Completed: Oct 31, 2027
2 conditions2 sponsors2 locations
NCT06976619
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
PHASE2Recruiting
60 participants
Started: Oct 3, 2025 · Completed: Mar 31, 2029
2 conditions1 sponsor1 location
NCT07158034
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
NARecruiting
24 participants
Started: Oct 3, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
PHASE2/PHASE3Recruiting
1,092 participants
Started: Oct 3, 2025 · Completed: Oct 6, 2032
1 condition1 sponsor9 locations
NCT07149857
A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
PHASE2Recruiting
60 participants
Started: Oct 3, 2025 · Completed: Dec 29, 2028
1 condition1 sponsor6 locations
NCT07176416
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
N/ARecruiting
50 participants
Started: Oct 3, 2025 · Completed: Oct 1, 2026
1 condition2 sponsors1 location
NCT06858787
Validating CGM for GDM
NARecruiting
150 participants
Started: Oct 2, 2025 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT07207811
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
PHASE3Recruiting
1,280 participants
Started: Oct 2, 2025 · Completed: Jun 29, 2029
1 condition1 sponsor271 locations
NCT06957535
Community-led Navigation to Address Disparities in Mammography Among Native American Women
NARecruiting
200 participants
Started: Oct 2, 2025 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT06851780
Analyzing Postural Parameters in Physiotherapy and Rehabilitation Students
N/ARecruiting
74 participants
Started: Oct 2, 2025 · Completed: Feb 21, 2026
2 conditions1 sponsor1 location
NCT06851793
Investigating Postural Parameters in Different Hip Pathologies
N/ARecruiting
66 participants
Started: Oct 2, 2025 · Completed: Mar 20, 2026
1 condition1 sponsor1 location
NCT07054723
Surviving Daily Life
N/ARecruiting
30 participants
Started: Oct 2, 2025 · Completed: Oct 31, 2026
6 conditions1 sponsor1 location
NCT06952790
Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study
NARecruiting
25 participants
Started: Oct 2, 2025 · Completed: May 1, 2026
1 condition1 sponsor1 location